The Provider’s Edge
Increase Productivity Increase Profit
I didn’t go into medicine to be a cardiac surgeon with Dr. Thomas MacGillivray
WED, 01 JUL 2020 00:00:00 -0500 ◦ 38 MINUTES
Dr. Thomas E. MacGillivray, MD is a national top cardiothoracic surgeon currently working at Houston Methodist Hospital, the DeBakey Heart & Vascular center as the Chief of Cardiac Surgery and Thoracic Transplant Surgery, as well as the Jimmy Howell Endowed Chair in Cardiovascular Surgery. Previously, he was Co-Director of the Thoracic Aortic Center and Surgical Director of the Adult Congenital Heart Disease Program at Massachusetts General Hospital in Boston. Dr. MacGillivray currently serves as the Society’s Treasurer-Elect; he previously was Chair of the Council on Education and Member Service for the Society of Thoracic Surgery.
If you want to connect with Dr. MacGillivray visit https://www.houstonmethodist.org/heart-vascular/
Are you a busy and ambitious healthcare professional who is looking to advance in your career without feeling overwhelmed, undervalued, or underappreciated? Then sign up for our FREE 7-days online summit.
Reserve your seat at SabrinaRunbeck.com/summit
Have a topic or question you'd like to see covered on the show? Send an email to Sabrina@SabrinaRunbeck.com or message Sabrina on Instagram, Facebook, or LinkedIn @SabrinaRunbeck.
Recent Post
What Signals Tell Investors a HealthTech Company Is Built for the Long Term?
What Signals Tell Investors a HealthTech Company Is Built for the Long Term? Investors look for long-term healthtech winners by…
Why Raising Capital Isn’t About the Pitch—And What Investors Evaluate Instead
Why Raising Capital Isn’t About the Pitch And What Investors Evaluate Instead If investors say they love your vision but…
How Smart Founders Raise Capital Without a Final Product
How Smart Founders Raise Capital Without a Final Product Most HealthTech founders assume investor hesitation comes down to one thing:…
The Hidden Hiring Risks That Derail Fundraising Rounds
The Hidden Hiring Risks That Derail Fundraising Rounds Most founders assume investors evaluate teams the same way LinkedIn does: credentials,…
Inside the Investor Roundtable: What AI Startups Keep Getting Wrong
Inside the Investor Roundtable: What AI Startups Keep Getting Wrong Why deep tech isn’t enough, and what FemTech, diagnostics, and…
Why Clinician-Trusted AI Outperforms: Integration, Retention, and Results
Why Clinician-Trusted AI Outperforms: Integration, Retention, and Results AI models don’t scale because they’re smart. They scale because clinicians trust…
Don’t Bury the Lead: How to Package Your Proof So Investors Pay Attention (and Pay Up)
Don’t Bury the Lead: How to Package Your Proof So Investors Pay Attention (and Pay Up) When you have 10…
What Do Investors Really Want to Hear in a FemTech or Diagnostic Pitch?
What Do Investors Really Want to Hear in a FemTech or Diagnostic Pitch? Uncover how to turn your data and…
How Can Women’s Health Founders Translate Scientific Jargon Into Investor-Ready Messaging?
How Can Women’s Health Founders Translate Scientific Jargon Into Investor-Ready Messaging? Most founders believe their science should speak for itself.…
Protecting Wealth While Scaling a HealthTech Startup
Protecting Wealth While Scaling a HealthTech Startup What Financial Systems Protect HealthTech Founders From Scaling Chaos and Personal Risk? When…